Aphria signs letter of intent with SAQ to supply up to 12,000 kg of cannabis annually to Quebec market
Aphria becomes one of the first suppliers of adult-use cannabis to La Belle Province
LEAMINGTON, ON, Feb. 14, 2018 /CNW/ – Aphria Inc. (“Aphria” or the “Company”) (TSX: APH and US OTC: APHQF) today announced that it has signed a Letter of Intent with the Société des alcools du Québec (“SAQ”) to guarantee a supply of high-quality, safe and clean cannabis products for sale in the Quebec adult-use market through their retail outlets and e-commerce platform.
We’re thrilled to partner with the SAQ to supply the Quebec adult-use market with a variety of high-quality, safe and pure cannabis products. Aphria is uniquely positioned to meet the anticipated demand in Canada’s second-largest market and we are pleased to be working closely with the SAQ and its management team as one of the first suppliers to the province.
Vic Neufeld, Chief Executive Officer of Aphria.
Under the terms of the agreement, the Company will supply the Quebec market with up to 12,000 kg of branded cannabis products in the first year of the agreement, including cannabis oils and other derivative products and several strains of high-quality Ontario- and B.C.-grown dried cannabis flower.
We Have a Good Thing Growing.
Aphria Inc., one of Canada’s lowest cost producers, produces, supplies and sells medical cannabis. Located in Leamington, Ontario, the greenhouse capital of Canada. Aphria is truly powered by sunlight, allowing for the most natural growing conditions available. Aphria is committed to providing pharma-grade medical cannabis, superior patient care while balancing patient economics and returns to shareholders.
For more information, visit: www.aphria.ca
Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.